Poster 37
- Kelley Tangredi
- May 13, 2024
- 1 min read
Updated: Jun 29, 2024
Congenital ichthyosis subtype analysis of primary efficacy of a novel topical isotretinoin formulation (TMB-001): Results from the Phase 2b CONTROL study in patients with recessive X-linked and autosomal recessive lamellar congenital ichthyosis
Authors: Dedee F. Murrell, Joyce Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers, Kimmie Eads, Leslie Castelo-Soccio, Alan M. Mendelsohn, Jessica Raiz, Christopher G. Bunick on behalf of the CONTROL Study investigators

Poster 37